Tumor necrosis factor-alpha accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease.
about
Therapeutic targets in the ASK1-dependent stress signaling pathwaysA liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approachesRole of gut microbiota and Toll-like receptors in nonalcoholic fatty liver diseaseReactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver.What does irritable bowel syndrome share with non-alcoholic fatty liver disease?Additive effects of nicotine and high-fat diet on hepatic steatosis in male mice.Perturbations of lipid metabolism indexed by lipidomic biomarkers.Connection of Nicotine to Diet-Induced Obesity and Non-Alcoholic Fatty Liver Disease: Cellular and Mechanistic InsightsThe potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance.Mechanism of Hepatocyte Apoptosis.Inflammatory stress exacerbates hepatic cholesterol accumulation via disrupting cellular cholesterol export.Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis.Oxymatrine Induces Liver Injury through JNK Signalling Pathway Mediated by TNF-α In Vivo.Cyclooxygenase-2 promotes hepatocellular apoptosis by interacting with TNF-α and IL-6 in the pathogenesis of nonalcoholic steatohepatitis in rats.The Nutraceutic Silybin Counteracts Excess Lipid Accumulation and Ongoing Oxidative Stress in an In Vitro Model of Non-Alcoholic Fatty Liver Disease Progression.Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis.Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver disease.Apoptosis and non-alcoholic fatty liver diseases.
P2860
Q26999030-1214BD74-664B-4526-A2D0-A661469D134DQ28392033-B2D55AE6-C01A-4533-A4C2-01F5175870C4Q33780172-F7DA0743-1929-47A7-A107-1FBAA5490B0BQ34009236-252E0A83-7168-4763-A74D-EBDA14F384C3Q34983471-6AD11CC5-9F1E-47E7-9494-BB368C967DFFQ36439605-D3EB593E-DE0F-4616-9F7A-56CD54D8868AQ37512558-95C0AA93-1923-4E6A-B43B-98C5A31CCE57Q37634620-111E7D6F-D1BB-4DAE-8D0C-74F6FD739715Q37973510-2D1F24FF-9C9C-48D4-873E-0FE8911644A8Q38774266-A855A70E-5047-4DAB-A2A5-655ECCB465D5Q39440693-6E7A8886-970A-47BF-AEBF-E5B90EFDA651Q39559406-35DF00DB-9F8C-4AB9-8632-C74E2B31B6B3Q40789532-82CE8B2C-4597-42B1-8E54-3AA1C419DE1EQ42249904-FEC231CC-D253-48C0-91C5-93AF961D7346Q42362519-48823EF6-6D82-49B7-89F7-1F77EBAD79E3Q42367659-9C2D73AB-D582-4CD0-820F-F7DF69DE8D74Q42580307-FD81D4C8-C0F6-4E46-9FDC-3CC2988D7FEEQ55503094-4343359D-C98A-4181-98CF-D06DC6A3F273
P2860
Tumor necrosis factor-alpha accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Tumor necrosis factor-alpha ac ...... alcoholic fatty liver disease.
@en
Tumor necrosis factor-alpha ac ...... alcoholic fatty liver disease.
@nl
type
label
Tumor necrosis factor-alpha ac ...... alcoholic fatty liver disease.
@en
Tumor necrosis factor-alpha ac ...... alcoholic fatty liver disease.
@nl
prefLabel
Tumor necrosis factor-alpha ac ...... alcoholic fatty liver disease.
@en
Tumor necrosis factor-alpha ac ...... alcoholic fatty liver disease.
@nl
P2093
P1476
Tumor necrosis factor-alpha ac ...... alcoholic fatty liver disease.
@en
P2093
Hiroshi Kudo
Kazuhiro Tsukada
Kengo Kawai
Naihong Chen
Shiho Fujisaka
Terumi Takahara
Toshiro Sugiyama
P304
P356
10.1016/J.BBRC.2009.12.144
P407
P577
2009-12-31T00:00:00Z